硫氧还蛋白系统与miR-21、miR-23a/b及let-7a作为脑肿瘤进展的潜在生物标志物:初步病例数据
研究检测了16例胶质瘤、15例脑膜瘤、5例转移瘤和2例良性肿瘤组织中Trx-1、TrxR-1、PRDX-1及miR-21、miR-23a/b、let-7a、miR-125的表达,并检测36例脑肿瘤患者与37名健康志愿者血清蛋白水平;发现低级别肿瘤组织mRNA高表达但蛋白低表达,低级别患者血清蛋白较高,且miR-23b、miR-21、miR-23a、let-7a在低级别组织中高表达并与硫氧还蛋白系统活性正相关。
要点
- 低级别脑肿瘤组织中Trx-1、TrxR-1、PRDX-1 mRNA高表达但蛋白低表达。
- 低级别脑肿瘤患者血清中Trx-1、TrxR-1、PRDX-1蛋白表达较高。
- miR-23b、miR-21、miR-23a、let-7a在低级别组织中高表达并与硫氧还蛋白系统活性正相关。
核心结论
- Trx-1、TrxR-1、miR-21、miR-23a/b和let-7a可能用于临床脑肿瘤诊断。
- 需要进一步的前瞻性研究包括分子通路分析来验证miRNA/Trx系统调控轴在脑肿瘤进展中的作用。
研究设计与样本
- 研究检测了16例胶质瘤、15例脑膜瘤、5例转移瘤和2例良性肿瘤样本。
- 采用定量实时聚合酶链反应检测Trx-1、TrxR-1、PRDX-1 mRNA及miR-23a、miR-23b、miR-125a、miR-21、let-7a表达水平,Western blot检测蛋白水平。
- 采用酶联免疫吸附试验检测36例脑肿瘤患者和37名健康志愿者血清中Trx-1、TrxR-1、PRDX-1蛋白水平。
主要发现
- 低级别脑肿瘤组织中Trx-1、TrxR-1、PRDX-1呈现高mRNA表达但低蛋白表达。
- 低级别脑肿瘤患者血清中Trx-1、TrxR-1、PRDX-1蛋白表达较高。
- miR-23b、miR-21、miR-23a、let-7a在低级别脑肿瘤组织中高表达,并与硫氧还蛋白系统活性增加正相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步的前瞻性研究包括分子通路分析来验证miRNA/Trx系统调控轴在脑肿瘤进展中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The thioredoxin system and microRNAs (miRNAs) are potential targets for both cancer progression and treatment. However, the role of miRNAs and their relation with the expression profile of thioredoxin system in brain tumor progression remains unclear. METHODS: In this study, we aimed to determine the expression profiles of redox components Trx-1, TrxR-1 and PRDX-1, and oncogenic miR-21, miR-23a/b and let-7a and oncosuppressor miR-125 in different brain tumor tissues and their association with increasing tumor grade. We studied Trx-1, TrxR-1, and PRDX-1 messenger RNA expression levels by quantitative real-time polymerase chain reaction and protein levels by Western blot and miR-23a, miR-23b, miR-125a, miR-21, and let-7a miRNA expression levels by quantitative real-time polymerase chain reaction in 16 glioma, 15 meningioma, 5 metastatic, and 2 benign tumor samples. We also examined Trx-1, TrxR-1, and PRDX-1 protein levels in serum samples of 36 patients with brain tumor and 37 healthy volunteers by enzyme-linked immunosorbent assay. RESULTS: We found that Trx-1, TrxR-1, and PRDX-1 presented high messenger RNA expression but low protein expression in low-grade brain tumor tissues, whereas they showed higher protein expression in sera of patients with low-grade brain tumors. miR-23b, miR-21, miR-23a, and let-7a were highly expressed in low-grade brain tumor tissues and positively correlated with the increase in thioredoxin system activity. CONCLUSIONS: Our findings showed that Trx-1, TrxR-1, miR-21, miR-23a/b, and let-7a might be used for brain tumor diagnosis in the clinic. Further prospective studies including molecular pathway analyses are required to validate the miRNA/Trx system regulatory axis in brain tumor progression.
引用
- Kılıç N, Boyacıoğlu Ö, Saltoğlu GT, et al. Thioredoxin System and miR-21, miR-23a/b and let-7a as Potential Biomarkers for Brain Tumor Progression: Preliminary Case Data. World Neurosurg. 2022. PMID: 36096386. doi:10.1016/j.wneu.2022.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。